Segantii Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-100,000
| Closed | -$1.01M | – | 293 |
|
|
2023
Q1 | $1.01M | Hold |
100,000
| – | – | 0.04% | 160 |
|
|
2022
Q4 | $998K | Hold |
100,000
| – | – | 0.04% | 195 |
|
|
2022
Q3 | $971K | Hold |
100,000
| – | – | 0.03% | 250 |
|
|
2022
Q2 | $969 | Hold |
100,000
| – | – | 0.02% | 245 |
|
|
2022
Q1 | $975K | Hold |
100,000
| – | – | 0.03% | 253 |
|
|
2021
Q4 | $981K | Hold |
100,000
| – | – | 0.03% | 196 |
|
|
2021
Q3 | $983K | Buy |
+100,000
| New | +$983K | 0.03% | 188 |
|